Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation

Verapamil is a calcium channel blocker and highly effective in the treatment of hypertension, angina pectoris, and other diseases. However, the drug has a low bioavailability of 20 to 35% due to the first pass effect. The main objective of this study was to develop hybrid verapamil-dextran nanostruc...

Full description

Bibliographic Details
Main Authors: Khan, Arshad Ali, Abdulbaqi, Ibrahim M., Assi, Reem Abou, Vikneswaran, Murugaiyah, Yusrida, Darwis
Format: Article
Language:English
Published: Springer Open 2018
Subjects:
Online Access:http://umpir.ump.edu.my/id/eprint/29850/
http://umpir.ump.edu.my/id/eprint/29850/1/Lyophilized%20hybrid%20nanostructured%20lipid%20carriers%20to%20enhance%20the%20cellular.pdf
_version_ 1848823379112493056
author Khan, Arshad Ali
Abdulbaqi, Ibrahim M.
Assi, Reem Abou
Vikneswaran, Murugaiyah
Yusrida, Darwis
author_facet Khan, Arshad Ali
Abdulbaqi, Ibrahim M.
Assi, Reem Abou
Vikneswaran, Murugaiyah
Yusrida, Darwis
author_sort Khan, Arshad Ali
building UMP Institutional Repository
collection Online Access
description Verapamil is a calcium channel blocker and highly effective in the treatment of hypertension, angina pectoris, and other diseases. However, the drug has a low bioavailability of 20 to 35% due to the first pass effect. The main objective of this study was to develop hybrid verapamil-dextran nanostructured lipid carriers (HVD-NLCs) in an attempt to increase verapamil cellular uptake. The formulations were successfully prepared by a high-shear homogenization method and statistically optimized using 24 full factorial design. The HVD-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. The results showed that the optimized formula (VER-9) possessed a particle size (PS), polydispersity index (PDI), and the percentage of entrapment efficiency (%EE) of 192.29 ± 2.98, 0.553 ± 0.075, and 93.26 ± 2.66%, respectively. The incorporation of dextran sulfate in the formulation had prolonged the release of verapamil (~ 85% in 48 h) in the simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8). The differential scanning calorimetry analysis showed no chemical interaction between verapamil and the excipients in the formulation. While wide-angle X-ray scattering studies demonstrated the drug in the amorphous form after the incorporation in the NLCs. The transmission electron microscopy and scanning electron microscopy images revealed that the nanoparticles had spherical shape. The cellular uptake study using Caco-2 cell line showed a higher verapamil uptake from HVD-NLCs as compared to verapamil solution and verapamil-dextran complex. The optimized formulation (VER-9) stored in the refrigerated condition (5 °C ± 3 °C) was stable for 6 months. In conclusion, the HVD-NLCs were potential carriers for verapamil as they significantly enhanced the cellular uptake of the drug.
first_indexed 2025-11-15T02:56:12Z
format Article
id ump-29850
institution Universiti Malaysia Pahang
institution_category Local University
language English
last_indexed 2025-11-15T02:56:12Z
publishDate 2018
publisher Springer Open
recordtype eprints
repository_type Digital Repository
spelling ump-298502020-11-13T07:03:44Z http://umpir.ump.edu.my/id/eprint/29850/ Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation Khan, Arshad Ali Abdulbaqi, Ibrahim M. Assi, Reem Abou Vikneswaran, Murugaiyah Yusrida, Darwis TP Chemical technology Verapamil is a calcium channel blocker and highly effective in the treatment of hypertension, angina pectoris, and other diseases. However, the drug has a low bioavailability of 20 to 35% due to the first pass effect. The main objective of this study was to develop hybrid verapamil-dextran nanostructured lipid carriers (HVD-NLCs) in an attempt to increase verapamil cellular uptake. The formulations were successfully prepared by a high-shear homogenization method and statistically optimized using 24 full factorial design. The HVD-NLCs formulations were freeze-dried using trehalose as a cryoprotectant. The results showed that the optimized formula (VER-9) possessed a particle size (PS), polydispersity index (PDI), and the percentage of entrapment efficiency (%EE) of 192.29 ± 2.98, 0.553 ± 0.075, and 93.26 ± 2.66%, respectively. The incorporation of dextran sulfate in the formulation had prolonged the release of verapamil (~ 85% in 48 h) in the simulated gastric fluid (pH 1.2) and simulated intestinal fluid (pH 6.8). The differential scanning calorimetry analysis showed no chemical interaction between verapamil and the excipients in the formulation. While wide-angle X-ray scattering studies demonstrated the drug in the amorphous form after the incorporation in the NLCs. The transmission electron microscopy and scanning electron microscopy images revealed that the nanoparticles had spherical shape. The cellular uptake study using Caco-2 cell line showed a higher verapamil uptake from HVD-NLCs as compared to verapamil solution and verapamil-dextran complex. The optimized formulation (VER-9) stored in the refrigerated condition (5 °C ± 3 °C) was stable for 6 months. In conclusion, the HVD-NLCs were potential carriers for verapamil as they significantly enhanced the cellular uptake of the drug. Springer Open 2018-10-15 Article PeerReviewed pdf en cc_by_4 http://umpir.ump.edu.my/id/eprint/29850/1/Lyophilized%20hybrid%20nanostructured%20lipid%20carriers%20to%20enhance%20the%20cellular.pdf Khan, Arshad Ali and Abdulbaqi, Ibrahim M. and Assi, Reem Abou and Vikneswaran, Murugaiyah and Yusrida, Darwis (2018) Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation. Nanoscale Research Letters, 13 (323). pp. 1-16. ISSN 1556-276X. (Published) https://doi.org/10.1186/s11671-018-2744-6 https://doi.org/10.1186/s11671-018-2744-6
spellingShingle TP Chemical technology
Khan, Arshad Ali
Abdulbaqi, Ibrahim M.
Assi, Reem Abou
Vikneswaran, Murugaiyah
Yusrida, Darwis
Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title_full Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title_fullStr Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title_full_unstemmed Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title_short Lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
title_sort lyophilized hybrid nanostructured lipid carriers to enhance the cellular uptake of verapamil: statistical optimization and in vitro evaluation
topic TP Chemical technology
url http://umpir.ump.edu.my/id/eprint/29850/
http://umpir.ump.edu.my/id/eprint/29850/
http://umpir.ump.edu.my/id/eprint/29850/
http://umpir.ump.edu.my/id/eprint/29850/1/Lyophilized%20hybrid%20nanostructured%20lipid%20carriers%20to%20enhance%20the%20cellular.pdf